Sarcoma trials in Brazil
7 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Belo Horizonte, Itajaí, Porto Alegre, São Paulo
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barretos, Curitiba, Porto Alegre, São José do Rio Preto
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 3Taking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Barretos, Belo Horizonte, Ijuí, Natal, Passo Fundo, Porto Alegre, Recife, Rio de Janeiro, Teresina
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - Phase 2Taking peopleA Study of Propranolol to Treat Kaposi Sarcoma
- Where
- Rio de Janeiro, Salvador
- People
- 25 worldwide
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT05797662 - No phaseTaking peopleInternational Rare Brain Tumor Registry
- Where
- São Paulo
- Age
- Up to 45 years
- People
- 5,800 worldwide
- Run by
- Children's National Research Institute
See details and how to joinNCT05697874 - No phaseTaking peopleProspective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- Where
- Liberdade
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Australia and New Zealand Sarcoma Association
See details and how to joinNCT07377747 - No phaseTaking peopleObservational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
- Where
- São Paulo
- Age
- 18 years to 120 years
- People
- 5,000 worldwide
- Run by
- Grupo Espanol de Investigacion en Sarcomas
See details and how to joinNCT04181970